Jasper Therapeutics, Inc. - Class A Common Stock (JSPR)
6.0600
-0.6400 (-9.55%)
Jasper Therapeutics Inc. is a biopharmaceutical company focused on developing innovative therapeutics to address critical unmet medical needs, particularly in the fields of hematology and oncology
The company is committed to advancing transformative therapies that enhance patient outcomes and improve the quality of life through cutting-edge research and development. Jasper Therapeutics leverages its proprietary technologies and expertise to create novel treatments that aim to tackle complex diseases, fostering collaborations to expedite the delivery of its breakthroughs to patients in need.
Frequently Asked Questions
Is Jasper Therapeutics, Inc. - Class A Common Stock publicly traded?
Yes, Jasper Therapeutics, Inc. - Class A Common Stock is publicly traded.
What exchange does Jasper Therapeutics, Inc. - Class A Common Stock trade on?
Jasper Therapeutics, Inc. - Class A Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Jasper Therapeutics, Inc. - Class A Common Stock?
The ticker symbol for Jasper Therapeutics, Inc. - Class A Common Stock is JSPR on the Nasdaq Stock Market
What is the current price of Jasper Therapeutics, Inc. - Class A Common Stock?
The current price of Jasper Therapeutics, Inc. - Class A Common Stock is 6.060
When was Jasper Therapeutics, Inc. - Class A Common Stock last traded?
The last trade of Jasper Therapeutics, Inc. - Class A Common Stock was at 4:00 pm EST on January 31st, 2025